Australian researchers have discovered a drug that slows the progression of Alzheimer's disease.
Neuroimmunologist Dr Gilles Guillemin of the University of NSW, has discovered a toxin that plays a key role in the development of Alzheimer's. If the production or effect of quinolinic acid could be blocked then it could slow the disease's progression.
For more information on this story:
Sydney Morning Herald
Reuters
News24, South Africa